Ärztlicher / Beruflicher Werdegang
- seit 2021
Junior Group Leader, Department of Cardiology, Angiology and Pneumology, Universitätsklinikum Heidelberg, Heidelberg, Germany
- 2020 – 2021
Senior Postdoctoral Research Fellow, Universitätsklinikum-Hamburg Eppendorf, Hamburg, Germany
- 2017 – 2020
Alexander von Humboldt Postdoctoral Research Fellow, Universitätsklinikum-Hamburg Eppendorf, Hamburg, Germany
- 2012 – 2017
Postdoctoral Research Fellow, Division of Endocrinology, BIDMC, Harvard University, Boston, USA
- 2007 – 2012
Graduate student, University of Graz, Graz, Austria
- 2003 – 2007
Junior Scientist, Dr. Reddy’s Laboratory, Hyderabad, India
Wissenschaftlicher Werdegang
- 2007 – 2012
PhD in Biochemistry and Molecular Cell Biology, University of Graz, Austria
- 2001 – 2003
Master of Science in Biochemistry, University of Pune, India
- 1998 – 2001
Bachelor of Science in Chemistry, University of Pune, India
Auszeichnungen
- 2017
Alexander von Humboldt Postdoctoral Research Fellowship
- 2016
American Diabetes Association, Oral Speaker, New Orleans, USA
- 2015
Keystone Symposia Award, Oral Speaker, Copenhagen, Denmark
- 2011
Keystone Symposia Award, Conference Assistant, Killarney, Ireland
- 2007
University International Postgraduate Award at UNSW, Australia (gracefully denied)
- 2003
NET (LS) Qualified by CSIR-UGC-NET, India
Stipendien
- 2017
Alexander von Humboldt Postdoctoral Research Fellowship
- 2007
University International Postgraduate Award at UNSW, Australia (gracefully denied)
- 2001 – 2003
Dr. Reddy’s Laboratory Masters Fellowship
Mitgliedschaften
German Centre for Cardiovascular Research (DZHK)
European Atherosclerosis Society (EAS)
American Heart Association (AHA)
American Diabetes Association (ADA)
Forschungsschwerpunkte
Activation of pro-inflammatory signaling pathways play a key role in the progression of skeletal and cardiovascular disorders. These pathways initiate cell-type specific transcriptional alterations and exert various metabolic effects via cellular cross-talk. We are interested in investigating the contribution of immuno-regulatory transcriptional pathways in the pathology of muscle disorders. Our focus is to increase the understanding on cellular and metabolic interactome involved in cellular remodeling by identifying novel therapeutic targets.